Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.44 |
| ▸ | FPR3 | P25089 | 4/20 | 0.41 |
| ▸ | FPR2 | P25090 | 4/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | HPGDS | O60760 | 1/20 | 0.40 |
| ▸ | KRAS | P01116 | 1/20 | 0.39 |
| ▸ | PLAT | P00750 | 1/20 | 0.38 |
| ▸ | POLR1A | O95602 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3681795 | 0.87 | KMT2A (0.44) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL26852111 | 0.84 | KMT2A (0.40) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL31364136 | 0.82 | RAB9A (0.40) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL9167791 | 0.82 | KMT2A (0.60) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL5654310 | 0.80 | KMT2A (0.62) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL17428293 | 0.80 | KMT2A (0.58) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL24649556 | 0.80 | KMT2A (0.42) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL1626503 | 0.79 | RAB9A (0.46) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL3680500 | 0.79 | RAB9A (0.46) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL20852069 | 0.79 | KDM4E (0.58) | KMT2ARAB9AALDH1A1KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028770-A1 | SURFACE MODIFIED MICROCAPSULES | INT FLAVORS & FRAGRANCES INC (US) | 2026-01-29 | — | — | US | claimed |
| US-12454791-B2 | Surface modified microcapsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-10-28 | — | — | US | claimed |
| CN-112423875-B | Surface-modified microcapsules | 国际香料和香精公司 | 2023-07-21 | — | — | CN | claimed |
| US-20210207317-A1 | SURFACE MODIFIED MICROCAPSULES | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2021-07-08 | — | — | US | claimed |
| EP-3801869-A1 | SURFACE MODIFIED MICROCAPSULES | International Flavors & Fragrances Inc. (US) | 2021-04-14 | — | — | EP | claimed |
| CN-112423875-A | Surface modified microcapsules | 国际香料和香精公司 | 2021-02-26 | — | — | CN | claimed |
| EP-1840136-B1 | Polymer dispersions, method for their manufacture and their application | CELANESE EMULSIONS GMBH (DE) | 2010-08-11 | — | — | EP | claimed |
| EP-1778804-B1 | SINGLE-COMPONENT SYSTEM BASED ON CO-REACTIVE LATEX, PREPARATION METHOD AND USE IN THE FIELD OF FORMOL-FREE COATINGS | ARKEMA FRANCE (FR) | 2010-01-20 | — | — | EP | claimed |
| US-20080028982-A1 | Single-Component System Based On Co-Reactive Latex, Preparation Method And Use In The Field Of Formol-Free Coatings | VERGE CHRISTOPHE | 2008-02-07 | — | — | US | claimed |
| US-20070244238-A1 | Polymer dispersions, process for the preparation thereof and the use thereof | CELANESE EMULSIONS GMBH (DE) | 2007-10-18 | — | — | US | claimed |
| EP-1147139-B1 | AQUEOUS COPOLYMER DISPERSION, ITS METHOD OF PRODUCTION AND ITS USE | CELANESE EMULSIONS GMBH (DE) | 2006-09-06 | — | — | EP | claimed |
| US-6727314-B2 | BLEND OF POLYMER COMPRISING ACETOACETOXYETHYL (METH)ACRYLATE AND CASTOR OIL (METH)ACRYLATE COMONOMERS | BASF AG (DE) | 2004-04-27 | — | — | US | claimed |
| US-20030195297-A1 | Crosslinking systems for acrylic latex films | BASF AG (DE) | 2003-10-16 | — | — | US | claimed |
| EP-0875541-B1 | Single phase system based on coreactive latex resins | ATOFINA (FR) | 2003-09-10 | — | — | EP | claimed |
| EP-0710680-B1 | Aqueous polymer dispersion | BASF AG (DE) | 2003-03-19 | — | — | EP | claimed |
| EP-0875540-B1 | Single phase system based on coreactive latex resins | ATOFINA (FR) | 2002-11-13 | — | — | EP | claimed |
| US-6133365-A | THE TWO LATEXES WHICH MAKE UP THE MIXTURE OF CROSSLINKABLE MONOMERS ARE FUNCTIONALIZED, ONE BY A GROUP OF THE UREIDO TYPE AND THE OTHER BY A GROUP OF N-ALKYLOL TYPE AND CAN BE MIXED WITHOUT REACTION DURING STORAGE | ATOFINA (FR) | 2000-10-17 | — | — | US | claimed |
| US-6107391-A | MIXTURE OF TWO PARTICLE DISPERSIONS, EACH OBTAINED BY AQUEOUS EMULSION POLYMERIZATION; ONE FROM AN UNSATURATED MONOMER WITH UREA GROUPS; THE OTHER FROM AN UNSATURATED ALDEHYDE; LATEX BINDERS FOR COATINGS; STORAGE STABILITY; LOW-TEMP CROSSLINK | ELF ATOCHEM S.A. (FR) | 2000-08-22 | — | — | US | claimed |
| US-5213901-A | Paint binder containing a film former and polymeric composition | ROHM AND HAAS COMPANY (US) | 1993-05-25 | — | — | US | claimed |
| US-5157071-A | Paints and polymers for use therein | UNION OIL COMPANY OF CALIFORNIA (US) | 1992-10-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028770-A1 | SURFACE MODIFIED MICROCAPSULES | CHRM5, TAS2R45, TAS2R42 | KMT2A 3276/4885RAB9A 1221/4885ALDH1A1 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.